| Drug Patent Number | Company | Drug Patent Title | Drug Patent Expiry | Activity Alert |
|---|---|---|---|---|
| These drug patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc). | ||||
|
US5196444 (Pediatric) | ANI PHARMS | 1-(cyclohexyloxycarbonyloxy)ethyl 2-ethoxy-1-[[2'-(1H-tetrazol-5-yl)biphenyl-4-yl]methyl]benzimidazole-7-carboxylate and compositions and methods of pharmaceutical use thereof |
Dec, 2012
(11 years ago) | |
| US5534534 | ANI PHARMS | Pharmaceutical compositions for oral use and method of preparing them |
Jul, 2013
(10 years ago) | |
|
US5534534 (Pediatric) | ANI PHARMS | Pharmaceutical compositions for oral use and method of preparing them |
Jan, 2014
(10 years ago) | |
Atacand is owned by Ani Pharms.
Atacand contains Candesartan Cilexetil.
Atacand has a total of 3 drug patents out of which 3 drug patents have expired.
Expired drug patents of Atacand are:
- US5196444*PED
- US5534534
- US5534534*PED
Atacand was authorised for market use on 04 June, 1998.
Atacand is available in tablet;oral dosage forms.
The generics of Atacand are possible to be released after 09 January, 2014.
Drugs and Companies using CANDESARTAN CILEXETIL ingredient
Market Authorisation Date: 04 June, 1998
Treatment: NA
Dosage: TABLET;ORAL
How can I launch a generic of ATACAND before it's drug patent expiration?
More Information on Dosage
ATACAND family patents
